Literature DB >> 30143887

Blood CRP levels are elevated in children and adolescents with functional neurological symptom disorder.

Kasia Kozlowska1,2,3, Jason Chung4,5, Bronya Cruickshank6, Loyola McLean7,8, Stephen Scher9,10,11, Russell C Dale5,12, Shekeeb S Mohammad5,13, Davinder Singh-Grewal5,14,15, Mukesh Yajaman Prabhuswamy6,16,17, Ellis Patrick18,19.   

Abstract

There is accumulating evidence that patients with functional neurological symptom disorder (FND) show activation of multiple components of the stress system-the hypothalamic-pituitary-adrenal axis, autonomic nervous system, and brain regions involved in arousal- and emotion-processing. This study aims to examine whether the immune-inflammatory component of the stress system is also activated. C-reactive protein (CRP) blood titre levels were measured in 79 children and adolescents with FND. CRP values ≥ 2 mg/L suggest low-grade inflammation. CRP values > 10 mg/L suggest a disease process. Sixty-six percent of subjects (n = 52) had CRP titres ≥ 2 mg/L. The upward shift in the distribution of CRP levels suggested low-grade inflammation (median CRP concentration was 4.60 mg/L, with 75th and 90th percentiles of 6.1 and 10.3 mg/L, respectively). Elevated CRP titres were not explained by sex, pubertal status, BMI, or medical factors. Confounder analyses suggested that history of maltreatment (χ2 = 2.802, df = 1, p = 0.094, φ = 0.190; β = 2.823, p = 0.04) and a diagnosis of anxiety (χ2 = 2.731, df = 1, p = 0.098, φ = 0.187; β = 4.520, p = 0.061) contributed to elevated CRP levels. Future research will need to identify the origins and locations of immune cell activation and the pathways and systems contributing to their activation and modulation. Because functional activity in neurons and glial cells-the brain's innate effector immune cells-is tightly coupled, our finding of elevated CRP titres suggests activation of the immune-inflammatory component of the brain's stress system. A more direct examination of inflammation-related molecules in the brain will help clarify the role of immune-inflammatory processes in FND.

Entities:  

Keywords:  Conversion disorder; Dissociation; Functional neurological symptoms; Neuroinflammation; Non-epileptic seizures

Mesh:

Substances:

Year:  2018        PMID: 30143887     DOI: 10.1007/s00787-018-1212-2

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  4 in total

1.  Autonomic, Endocrine, and Inflammation Profiles in Functional Neurological Disorder: A Systematic Review and Meta-Analysis.

Authors:  Sara Paredes-Echeverri; Julie Maggio; Indrit Bègue; Susannah Pick; Timothy R Nicholson; David L Perez
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2021-10-29       Impact factor: 2.198

2.  FAM89A and IFI44L for distinguishing between viral and bacterial infections in children with febrile illness.

Authors:  Shufeng Tian; Jikui Deng; Wenhua Huang; Linlin Liu; Yunsheng Chen; Yongqiang Jiang; Gang Liu
Journal:  Pediatr Investig       Date:  2021-09-22

3.  Assessment of cytokines, microRNA and patient related outcome measures in conversion disorder/functional neurological disorder (CD/FND): The CANDO clinical feasibility study.

Authors:  Christina van der Feltz-Cornelis; Sally Brabyn; Jonathan Ratcliff; Danielle Varley; Victoria Allgar; Simon Gilbody; Chris Clarke; Dimitris Lagos
Journal:  Brain Behav Immun Health       Date:  2021-02-24

4.  Functional Neurological Symptom Disorder (FND) Leading to the Development of Deep Vein Thrombosis (DVT).

Authors:  Ahmad Othman; Arthur Cecchini; Amira Eftaiha; Nneka Nwosisi; Deidre Pierce
Journal:  Cureus       Date:  2022-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.